BioSpace News Archive

Jiangsu Recbio Technology Co., Ltd. is pleased to announce that in accordance with the Mongolian law on the prevention of novel coronavirus outbreak, the Company was granted an Emergency Use Authorization for its two-component recombinant COVID-19 vaccine ReCOV by Order No. A106 of the Minister of Public Health of Mongolia and a resolution of the Mongolian Committee for Medicinal Products for Human Use.

Scorpius BioManufacturing, a Texas-based biologics contract research and contract development & manufacturing organization, announced the appointment of Gary Welch as Interim President.

Selecta Biosciences, Inc. and Sobi®, announced positive topline results from the Phase 3 DISSOLVE I & II placebo controlled randomized clinical trials to determine safety and efficacy of two different dose levels of SEL-212 in adult patients with chronic refractory gout.

NUCLIDIUM announced that the Neuroendocrine Tumors Research Foundation has selected the company and its collaboration partner the University Hospital Basel as recipients of its Investigator Award.

Cerevel Therapeutics today announced that chairperson and chief executive officer Tony Coles, M.D., will participate in a fireside chat at the Stifel Virtual 2023 CNS Days on Wednesday, March 29, 2023 at 10:30 am ET.

Mereo BioPharma Group plc (NASDAQ: MREO) (Mereo or the Company) today announced regulatory feedback following recent end-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) related to its alvelestat program for the treatment of alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD).